Back
Cardinal Health, Inc. (CAH)
Health CareCAH · NEW YORK STOCK EXCHANGE, INC. · USD
New to investing? How to read this page →$235.63
+0.83%Price · 1 year
Loading live analysis…
Loading analysis…
Intrinsic Investor is for education and research only — not financial advice.
Key metrics
EPS
$6.45
ROE
Gross margin
3.8%
Debt/Equity
Revenue growth
11.0%
P/B ratio
Beta
Forward P/E
Cardinal Health, Inc. — company intelligence
Earnings surprises
Q3 2026$3.17 vs $2.82 est+12.6%
Q2 2026$2.63 vs $2.40 est+9.4%
Q1 2026$2.55 vs $2.20 est+15.9%
Q4 2025$2.08 vs $2.06 est+1.1%
Insider activity · 90 days
1 buy0 sellsnet +381 shares
Hall Patricia HemingwayBuy 381 · Apr 15, 2026
Recent SEC filings
8-K — Material event reportApr 30, 2026
10-Q — Quarterly reportApr 30, 2026
4 — Insider transaction reportApr 17, 2026
Latest news
Cardinal Health: Why This Essential Healthcare Distributor Deserves A Buy Rating — SeekingAlpha · 1w ago
B of A Securities Maintains Buy on Cardinal Health, Raises Price Target to $260 — Benzinga · 1w ago
Are Investors Undervaluing Cardinal Health (CAH) Right Now? — Yahoo · 1w ago
Cardinal Health: I Sold In 2024, Reviewing 2026 (Rating Downgrade) — SeekingAlpha · 1w ago
Why the Market Dipped But Cardinal Health (CAH) Gained Today — Yahoo · 2w ago
AI Valuation Narrative
Generates a short bull / bear / catalyst summary from the analytics we already computed. No target prices. Research tool, not investment advice.
Explore more
Peers & similar stocks
Quick links to related tickers for research.
About Cardinal Health, Inc.
Weekly undervalued picks (like CAH)
Get 3 new value ideas and the fair-value math behind them every week. One email, unsubscribe anytime.
Free. No spam. We only email once per week.
Data is provided "as-is" and may be delayed or incomplete. Intrinsic Investor is for education only and is not investment advice.